Acp-103-059
ClinicalTrials.gov NCT03968159
Research payments
$3,982,767
Through program year 2021, $3,982,767 in research payments was reported against Acp-103-059, across 375 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT03968159
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $145,644 | 33 |
| 2020 | Research | $1,817,225 | 207 |
| 2019 | Research | $2,019,898 | 135 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Philip Bolton Portland, OR Named on 21 payments
- Bethany Davis Atlanta, GA Named on 18 payments
- Sonia Rente Miami, FL Named on 18 payments
- Anita Varma Memphis, TN Named on 15 payments
- Daniel Rutrick Watertown, MA Named on 15 payments
- John Joyce Jacksonville, FL Named on 15 payments
- Linda Harper Orlando, FL Named on 15 payments
- Michael Liebowitz New York, NY Named on 13 payments
- Nick Vatakis New York, NY Named on 13 payments
- Daniel Chueh Orange, CA Named on 12 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.